Concepedia

Clark A. Briggs

CA

4

Publications

392

Citations

4

H-Index

1991

Active since

Affiliations

Abbott (United Kingdom)(Current)

Abbott Fund

Clark A. Briggs is an author at Abbott (United Kingdom) specializing in pharmacotherapy, molecular pharmacology, and drug discovery.

Top concepts

Publications per year

1991–1998

4

Publications

4

A-85380 [3-(2(S)-azetidinylmethoxy) pyridine]: In Vitro pharmacological properties of a novel, high affinity α4β2 nicotinic acetylcholine receptor ligand

James P. Sullivan, Diana L. Donnelly‐Roberts, Clark A. Briggs et al. · Neuropharmacology · 1996 · 137 citations · Full text

, , +7

ABT-594 [(R)-5-(2-Azetidinylmethoxy)-2-Chloropyridine]: A Novel, Orally Effective Analgesic Acting via Neuronal Nicotinic Acetylcholine Receptors: I. In Vitro Characterization

Diana L. Donnelly‐Roberts, Pamela S. Puttfarcken, Theresa A. Kuntzweiler et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 103 citations

ABT-089 [2-Methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A Potent and Selective Cholinergic Channel Modulator with Neuroprotective Properties

James P. Sullivan, Diana L. Donnelly‐Roberts, Clark A. Briggs et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 78 citations

Activation of the 5‐HT<sub>1c</sub>receptor expressed in<i>Xenopus</i>oocytes by the benzazepines SCH 23390 and SKF 38393

Clark A. Briggs, Nancy J. Pollock, Donald E. Frail et al. · British Journal of Pharmacology · 1991 · 74 citations · Full text

Rows per page

1–4 of 4